Clinical evaluation of lysuride in the management of hyperprolactinaemia.
- 23 May 1987
- Vol. 294 (6583) , 1323-1324
- https://doi.org/10.1136/bmj.294.6583.1323-a
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- SURVIVAL AND RENAL FUNCTION IN UNTREATED HYPERCALCAEMIAThe Lancet, 1987
- Rapid regression of macroprolactinomas by the new dopamine partial agonist tergurideActa Endocrinologica, 1986
- Intolerance of bromocriptine: is metergoline a satisfactory alternative?BMJ, 1985
- COMPARISON OF THE CLINICAL ACTIVITY OF MESULERGINE AND PERGOLIDE IN THE TREATMENT OF HYPERPROLACTINAEMIAClinical Endocrinology, 1985
- Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*Journal of Clinical Endocrinology & Metabolism, 1981